Long-term administration of aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia in infants and children with symptomatic human immunodeficiency virus infection

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 2, 1996, Pages 158-163

  Principi, Nicola ^a   Marchisio, Paola ^a   Onorato, Josè ^a   Gabiano, Clara ^b   Galli, Luisa ^c   Caselli, Desireè ^d   Morandi, Beatrice ^a   Campelli, Antonio ^e   Clerici, Maggie ^a   Gattinara, Guido Castelli ^f  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Aerosolized pentamidine; Children; Human immunodeficiency virus infection; Pneumocystis carinii prophylaxis

Indexed keywords

PENTAMIDINE; PENTAMIDINE ISETHIONATE;

ANTIVIRAL ACTIVITY; ARTICLE; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; DRUG SAFETY; EYE IRRITATION; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NAUSEA; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SNEEZING;

HUMAN IMMUNODEFICIENCY VIRUS; PNEUMOCYSTIS CARINII;

EID: 1542744699     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199606010-00009     Document Type: Article

References (31)

1. CDC. 1995 Revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected or perinatally exposed to human immunodeficiency virus. MMWR 1995;44:1-11.
2. Kovacs JA, Kovacs AAS. PCP prophylaxis in pediatric HIV infection: time for a change? Lancet 1994;344:5-6.
3. European Collaborative Study Group. CD4 T cell count as predictor of Pneumocystis carinii pneumonia in children born to mothers infected with HIV. BMJ 1994;308:437-40.
4. Simonds RJ, Lindergren ML, Thomas P, et al. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. N Engl J Med 1995;332:786-90.
5. Hughes WT, Rivera GK, Schell MJ, et al. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1987;316:1627-32.
6. Masur H. Prevention of Pneumocystis carinii pneumonia. Rev Infect Dis 1989;11:1664-8.
7. CDC. 1995 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR 1995;44:1-34.
8. Gordin FM, Simon GL, Wofsy CB, Mills J. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1984;100:495-9.
9. Chanock SJ, Luginbuhl LM, McIntosh K, Lipshultz SE. Life-threatening reaction to trimethoprim-sulfamethoxazole in pediatric human immunodeficiency virus infection. Pediatrics 1994;93:519-21.
10. Burger DM, Meenhorst PL, Koks CHW, Beijnen JH. Drugs interactions with zidovudine. AIDS 1993;7:445-60.
11. Safrin S, Lee BL, Sande MA. Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death. J Infect Dis 1994;170:912-17.
12. Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 1988;259:1185-9.
13. Caumes E, Roudier C, Rogeaux O, Bricaire F, Gentilini M. Effect of corticosteroids on the incidence of adverse cutaneous reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia. Clin Infect Dis 1994;18:319-23.
14. Ferdman RM, Church JA. Pneumocystis carinii pneumonia prophylaxis in HIV infected children. Pediatr AIDS HIV Infect 1992;3:235-41.
15. Sanders-Laufer D, Burroughs MH, Hinds GA, et al. Safety and efficacy of trimethoprim-sulfamethoxazole prophylaxis for treatment of Pneumocystis carinii pneumonia (PCP) in HIV infected children: a preliminary study. Proceedings of the 7th AIDS Clinical Trials Group Meeting. Bethesda: 1989:7.
16. McSherry G, Wright M, Oleske J, et al. Frequency of serious adverse reactions to trimethoprim-sulfamethoxazole and pentamidine among children with human immunodeficiency virus 1 (HIV-1) infection. Twenty-eighth Interscience Conference of Antimicrobial Agents and Chemotherapy. Abstract 1357. Los Angeles, 1988:353.
17. Bernard EM, Dickmeyer MS, Schmitt H, Armstrong D. Long term safety arid effectiveness of aerosol pentamidine for prevention of Pneumocystis carinii pneumonia. Abstract T.B.P. 53. Fifth international conference on AIDS. Montreal, June 1989.
18. Murphy RL, Lavelle JP, Davis Allan J, et al. Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients: results of a blinded dose-comparison study using an ultrasonic nebulizer. Am J Med 1991;114:418-26.
19. Montaner JSG, Lawson LM, Gervais A, et al. Aerosol pentamidine for secondary prophylaxis of AIDS-related Pneumocystis carinii pneumonia. Ann Intern Med 1991;114:948-53.
20. Katz BZ, Rosen C. Aerosolized pentamidine in young children. Pediatr Infect Dis J 1991;10:958.
21. Orcutt TA, Godwin CR, Pizzo PA, Ognibene FP. Aerosolized pentamidine: a well-tolerated mode of prophylaxis against Pneumocystis carinii pneumonia in older children with human immunodeficiency virus infection. Pediatr Infect Dis J 1992;11:290-4.
22. Hand IL, Wiznia AA, Porricolo M, Lambert G, Caspe WB. Aerosolized pentamidine for prophylaxis of Pneumocystis carinii in infants with immunodeficiency virus infection. Pediatr Infect Dis J 1994;13:100-4.
23. Mustafa MM, Pappo A, Cash J, Winick NJ, Buchanan GR. Aerosolized pentamidine for the prevention of Pneumocystis carinii pneumonia in children with cancer intolerant or allergic to trimethoprim-sulfamethoxazole. J Clin Oncol 1994;12:258-61.
24. Wienthal J, Frist JD, Briones G, Cairo MS. Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia. J Clin Oncol 1994;12:136-40.
25. O'Sullivan BP, Spaulding R. The use of aerosolized pentamidine for prophylaxis of Pneumocystis carinii pneumonia in children with leukemia. Pediatr Pulmonol 1994;18:228-31.
26. CDC. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994;43:RR12.
27. Rigaud M, Pollack H, Leibovitz E, et al. Efficacy of primary chemoprophylaxis against Pneumocystis carinii pneumonia during the first year of life in infants infected with human immunodeficiency virus type 1. J Pediatr 1994;125:476-80.
28. Mueller BU, Butler KM, Husson RN, Pizzo PA. Pneumocystis carinii pneumonia despite prophylaxis in children with human immunodeficiency virus infection. J Pediatr 1991;119:992-4.
29. Schuval S, Bonagura VR. Failure of pentamidine as prophylaxis for Pneumocystis carinii pneumonia in HIV infected children. Arch Pediatr Adolesc Med 1994;148:876-9.
30. O'Doherty MJ, Thomas SH, Gibb D, et al. Lung deposition of nebulised pentamidine in children. Thorax 1993;48:220-6.
31. Monk JP, Benfield P. Inhaled pentamidine. Drugs 1990;39:741-56.